Q Fever Endocarditis in Iran.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 10 2019
Historique:
received: 05 03 2019
accepted: 03 10 2019
entrez: 26 10 2019
pubmed: 28 10 2019
medline: 28 10 2020
Statut: epublish

Résumé

Patients with the underlying valvular heart disease are at the high risk of developing sub-acute or chronic endocarditis secondary to Coxiella burnetii. Q fever endocarditis is the most common manifestation along with persistent the infection. There is some serologic and molecular evidence of C. burnetii infection in humans and livestock in Iran. As it is possible to observe chronic Q fever in Iran, it seems necessary to study the prevalence of Q fever endocarditis in this country. In the present study, Infective Endocarditis (IE) patients (possible or definite based on Duke Criteria) hospitalized in Rajaie Cardiovascular Medical and Research Center were enrolled from August 2016 to September 2018. Culture-negative endocarditis patients were evaluated by Raoult criteria for diagnosis Q fever endocarditis. The serological results for brucellosis were negative for all subjects. All blood and tissue samples including valve samples were tested for C. burnetii infection using serology and Polymerase Chain Reaction (PCR). In this study, 126 patients who were admitted to the hospital were enrolled; of which 52 subjects were culture-negative IE. Among the participants, 16 patients (30.77%) were diagnosed with Q fever IE and underwent medical treatment. The mean age of patients was 46.6 years ranging from 23 to 69 years and 75% of them were male. Considering the high prevalence of Q fever IE, evaluation of the patients with culture-negative IE for C. burnetii infections was highly recommended.

Identifiants

pubmed: 31649268
doi: 10.1038/s41598-019-51600-3
pii: 10.1038/s41598-019-51600-3
pmc: PMC6813299
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15276

Références

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):35-7
pubmed: 24634687
Trop Doct. 2016 Oct;46(4):221-224
pubmed: 26767385
J Heart Valve Dis. 2014 Nov;23(6):735-43
pubmed: 25790621
Lancet Infect Dis. 2005 Apr;5(4):219-26
pubmed: 15792739
Appl Environ Microbiol. 2011 Oct;77(20):7405-7
pubmed: 21856829
PLoS Negl Trop Dis. 2017 Apr 10;11(4):e0005521
pubmed: 28394889
J Infect Public Health. 2015 Sep-Oct;8(5):498-501
pubmed: 25747823
Clin Infect Dis. 2006 Mar 15;42(6):818-21
pubmed: 16477559
Vector Borne Zoonotic Dis. 2014 Jan;14(1):41-5
pubmed: 24359427
PLoS One. 2016 Jan 05;11(1):e0144953
pubmed: 26731333
J Infect. 2012 Aug;65(2):102-8
pubmed: 22537659
J Antimicrob Chemother. 2012 Feb;67(2):269-89
pubmed: 22086858
PLoS Negl Trop Dis. 2017 Apr 10;11(4):e0005535
pubmed: 28394892
Iran J Microbiol. 2017 Aug;9(4):213-218
pubmed: 29238456
Emerg Infect Dis. 2012 Apr;18(4):563-70
pubmed: 22469535
Clin Infect Dis. 2017 Nov 13;65(11):1872-1877
pubmed: 29140515
Vector Borne Zoonotic Dis. 2014 Mar;14(3):189-92
pubmed: 24575713
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Clin Microbiol Rev. 2017 Jan;30(1):115-190
pubmed: 27856520
Vet Microbiol. 2010 Jan 27;140(3-4):297-309
pubmed: 19875249
J Infect. 2012 Mar;64(3):247-59
pubmed: 22226692
MMWR Recomm Rep. 2013 Mar 29;62(RR-03):1-30
pubmed: 23535757
Int J Antimicrob Agents. 1997;8(3):145-61
pubmed: 18611796
Lancet Infect Dis. 2010 Aug;10(8):527-35
pubmed: 20637694
Ann Agric Environ Med. 2013;20(4):708-10
pubmed: 24364439

Auteurs

Pardis Moradnejad (P)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Saber Esmaeili (S)

National Reference Laboratory for Plague, Tularemia and Q fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Iran.
Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging infectious diseases, Pasteur Institute of Iran, Tehran, Iran.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Majid Maleki (M)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Anita Sadeghpour (A)

Echocardiography Research center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Monireh Kamali (M)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Mahdi Rohani (M)

National Reference Laboratory for Plague, Tularemia and Q fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Iran.
Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.

Ahmad Ghasemi (A)

National Reference Laboratory for Plague, Tularemia and Q fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Iran.
Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging infectious diseases, Pasteur Institute of Iran, Tehran, Iran.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Fahimeh Bagheri Amiri (F)

National Reference Laboratory for Plague, Tularemia and Q fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Iran.

Hamid Reza Pasha (HR)

Echocardiography Research center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Shabnam Boudagh (S)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Hooman Bakhshandeh (H)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Nasim Naderi (N)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Behshid Ghadrdoost (B)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Sara Lotfian (S)

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Seyed Ali Dehghan Manshadi (SA)

Department of Infectious Diseases and Tropical Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Ehsan Mostafavi (E)

National Reference Laboratory for Plague, Tularemia and Q fever, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Iran. mostafaviehsan@gmail.com.
Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging infectious diseases, Pasteur Institute of Iran, Tehran, Iran. mostafaviehsan@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH